ConductScience.org, home
Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis
API referenceFor AI assistants

Trial · NCT00556439

Participant flow24

How many started, completed or left each group, period by period.

1 to 20 of 24

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Study Entry to Week 12STARTEDGroup A - Abatacept in Giant Cell Arteritis49
Study Entry to Week 12STARTEDGroup B - Placebo in Giant Cell Arteritis0
Study Entry to Week 12STARTEDGroup C - Abatacept in Takayasu Arteritis34
Study Entry to Week 12STARTEDGroup D - Placebo in Takayasu Arteritis0
Study Entry to Week 12COMPLETEDGroup A - Abatacept in Giant Cell Arteritis41
Study Entry to Week 12COMPLETEDGroup B - Placebo in Giant Cell Arteritis0
Study Entry to Week 12COMPLETEDGroup C - Abatacept in Takayasu Arteritis26
Study Entry to Week 12COMPLETEDGroup D - Placebo in Takayasu Arteritis0
Study Entry to Week 12NOT COMPLETEDGroup A - Abatacept in Giant Cell Arteritis8
Study Entry to Week 12NOT COMPLETEDGroup B - Placebo in Giant Cell Arteritis0
Study Entry to Week 12NOT COMPLETEDGroup C - Abatacept in Takayasu Arteritis8
Study Entry to Week 12NOT COMPLETEDGroup D - Placebo in Takayasu Arteritis0
After Week 12 (Randomized Study Period)STARTEDGroup A - Abatacept in Giant Cell Arteritis20
After Week 12 (Randomized Study Period)STARTEDGroup B - Placebo in Giant Cell Arteritis21
After Week 12 (Randomized Study Period)STARTEDGroup C - Abatacept in Takayasu Arteritis11
After Week 12 (Randomized Study Period)STARTEDGroup D - Placebo in Takayasu Arteritis15
After Week 12 (Randomized Study Period)COMPLETEDGroup A - Abatacept in Giant Cell Arteritis17
After Week 12 (Randomized Study Period)COMPLETEDGroup B - Placebo in Giant Cell Arteritis17
After Week 12 (Randomized Study Period)COMPLETEDGroup C - Abatacept in Takayasu Arteritis11
After Week 12 (Randomized Study Period)COMPLETEDGroup D - Placebo in Takayasu Arteritis14

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00556439/flow

API referenceFor AI assistants